Cases & Deals

Isis Pharmaceuticals builds patent portfolio for certain clinical development compounds

Clients Isis Pharmaceuticals, Inc.

On behalf of Isis Pharmaceuticals, Inc., Jones Day assisted with patent prosecution strategy and portfolio development concerning some of its clinical development compounds.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.